GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $24,000 | +4.3% | 600 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $23,000 | -47.7% | 600 | -52.0% | 0.01% | -50.0% |
Q4 2017 | $44,000 | +69.2% | 1,250 | +108.3% | 0.01% | +55.6% |
Q2 2017 | $26,000 | +4.0% | 600 | 0.0% | 0.01% | +12.5% |
Q1 2017 | $25,000 | -56.9% | 600 | -60.0% | 0.01% | -60.0% |
Q4 2016 | $58,000 | -4.9% | 1,500 | 0.0% | 0.02% | -4.8% |
Q1 2016 | $61,000 | 0.0% | 1,500 | 0.0% | 0.02% | -4.5% |
Q4 2015 | $61,000 | +5.2% | 1,500 | 0.0% | 0.02% | +4.8% |
Q3 2015 | $58,000 | -6.5% | 1,500 | 0.0% | 0.02% | 0.0% |
Q2 2015 | $62,000 | -10.1% | 1,500 | 0.0% | 0.02% | -12.5% |
Q1 2015 | $69,000 | +7.8% | 1,500 | 0.0% | 0.02% | +9.1% |
Q4 2014 | $64,000 | -20.0% | 1,500 | 0.0% | 0.02% | -15.4% |
Q2 2014 | $80,000 | 0.0% | 1,500 | 0.0% | 0.03% | -3.7% |
Q1 2014 | $80,000 | +66.7% | 1,500 | +66.7% | 0.03% | +42.1% |
Q4 2013 | $48,000 | +6.7% | 900 | 0.0% | 0.02% | 0.0% |
Q3 2013 | $45,000 | 0.0% | 900 | 0.0% | 0.02% | -5.0% |
Q2 2013 | $45,000 | – | 900 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |